High-risk vertical
Research-chemical language that clears underwriting, legal-entity structure for multi-peptide brands, and processor paths that actually stick past 90 days.
Stripe declines peptide operators by policy. Honest comparison of Authorize.net ISOs, NMI gateways, offshore acquirers, and parent-account orchestration.
How peptide operators register Apple Pay domains across multiple brands without tripping Apple's merchant review or acquirer compliance.
Honest comparison of SARMs-friendly merchant accounts: Authorize.net ISOs, NMI, offshore, and consolidated parent MIDs. Real rates, real reserves.
Honest 2026 ranking of payment processors for peptide operators. Who actually approves, real reserves, real rates, single-brand vs multi-brand picks.
Honest comparison of payment processors for nootropics subscription brands. Acquirer shortlist, rates, dunning-friendly features, multi-brand structure.
Honest 2026 guide to processing SARMs. Who approves, who declines, reserve structures, rates, and the multi-brand question.
Peptide operator playbook for preventing friendly fraud and true fraud chargebacks. Scripts, rules, representment templates, portfolio controls.
SARMs operator chargeback playbook. Pre-transaction rules, representment for research-chemical disputes, portfolio fraud controls.
How peptide operators configure billing descriptors to cut chargebacks, stay inside acquirer rules, and survive Visa VAMP scrutiny.
Peptide operator descriptor playbook: dynamic vs soft descriptors, keyword avoidance, multi-brand strategy, chargeback impact.
SARMs merchant account setup: approved acquirer shortlist, SKU review, rates, research-chemical compliance, portfolio structure.
Peptide operators on MATCH: the removal process that actually works, how long it takes, and the processors that still approve while you wait.
Peptide operators on MATCH face a specific subset of acquirers. Here is the escape plan that actually works and the paths that don't.
What SARMs startups actually need to open a merchant account in 2026 — acquirer list, docs, rates, reserves, and how to avoid MATCH on day one.
Honest 2026 payment processing rates for nootropics operators: what Stripe, Square, Authorize.net charge, risk adders, multi-brand pricing math.
Honest 2026 payment processing rates for peptide operators: what Stripe, Square, Authorize.net charge, risk adders, multi-brand pricing math.
Honest 2026 payment processing rates for SARMs operators: what Stripe, Square, Authorize.net charge, risk adders, multi-brand pricing math.
Full 2026 onboarding checklist for peptide operators: entity, banking, processing, compliance, site, fulfillment, CS, and reporting — in order.
You run a peptide lab with five consumer-facing brands. Every processor eventually freezes. Here is the stack that survives and the one that does not.
Peptide operator reserve structure decision: rolling vs upfront, cash flow implications, negotiation leverage, hybrid structures.
Plain list of processors that actually approve peptide brands, with real rates, real reserves, and what separates a sustainable approval from a 90-day close.
Step-by-step plan for peptide operators whose Stripe account got frozen. What to do in the first 48 hours, what not to do, and how to rebuild.
Honest 2026 comparison of payment processors for peptide operators. Who approves, who declines, real rates, real reserve structures.
Talk to an operator
Human reply within 2 business hours. No chatbot.